{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:19:46Z","timestamp":1780633186690,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jacc.2015.12.023","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T16:33:28Z","timestamp":1456158808000},"page":"907-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["Device Closure of Patent Foramen Ovale After Stroke"],"prefix":"10.1016","volume":"67","author":[{"given":"David M.","family":"Kent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa J.","family":"Dahabreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ruthazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Smalling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich P.","family":"Mattle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.12.023_bib1","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.113.001773","article-title":"Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials","volume":"44","author":"Kitsios","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.12.023_bib3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ccd.25122","article-title":"A\u00a0meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events","volume":"82","author":"Pineda","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.12.023_bib4","doi-asserted-by":"crossref","first-page":"e004282","DOI":"10.1136\/bmjopen-2013-004282","article-title":"Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"4","author":"Spencer","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2015.12.023_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.023_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.023_bib7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.023_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.023_bib9","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2015.12.023_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.annepidem.2005.09.007","article-title":"Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?","volume":"16","author":"Hernandez","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jacc.2015.12.023_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jclinepi.2003.09.014","article-title":"Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements","volume":"57","author":"Hernandez","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2015.12.023_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/STROKEAHA.108.532051","article-title":"Are unadjusted analyses of clinical trials inappropriately biased toward the null?","volume":"40","author":"Kent","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","article-title":"Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib14","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2015.12.023_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jacc.2015.12.023_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1745-6215-12-185","article-title":"The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke","volume":"12","author":"Kent","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2015.12.023_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2015.12.023_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.0000000000000589","article-title":"Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs","volume":"83","author":"Thaler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2015.12.023_bib20","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1161\/STROKEAHA.111.619577","article-title":"Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events","volume":"42","author":"Mono","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib21","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.023_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199207233270406","article-title":"Cumulative meta-analysis of therapeutic trials for myocardial infarction","volume":"327","author":"Lau","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.023_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jclinepi.2009.06.002","article-title":"A\u00a0substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals","volume":"63","author":"Austin","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2015.12.023_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","article-title":"Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)","volume":"101","author":"Taaffe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.023_bib25","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","article-title":"Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale","volume":"34","author":"Hornung","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.023_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2015.12.023_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","article-title":"Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Hakeem","year":"2013","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2015.12.023_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2015.12.023_bib29","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant versus antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2015.12.023_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.2010.1161","article-title":"Minimizing bias in randomized trials: the importance of blinding","volume":"304","author":"Psaty","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.12.023_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2016.04.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971507881X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971507881X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:47:04Z","timestamp":1718362024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971507881X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S073510971507881X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726180744.793533491","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Device Closure of Patent Foramen Ovale After Stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}